Protective Immune Response to 16 kDa Immunoreactive Recombinant Protein Encoding the C‐Terminal VP1 Portion of Foot and Mouth Disease Virus Type Asia 1
- 1 August 1999
- journal article
- Published by Wiley in Microbiology and Immunology
- Vol. 43 (8), 765-771
- https://doi.org/10.1111/j.1348-0421.1999.tb02468.x
Abstract
Recombinant protein of Foot and Mouth Disease Virus (FMDV) type Asia 1 corresponding to the C-terminal half of VP1 was expressed in Escherichia coli. As an alternative to the synthetic peptide, this selected C-terminal region was used as a protein vaccine in guinea pigs in order to study the immune response with various adjuvant formulations: immune stimulatory complexes (ISCOMs), Montanide ISA 206, Freund's incomplete adjuvant (FIA), lipopolysaccharide (LPS) and cytokine mixture. A primary dose of 40 microg/animal followed by a booster of the same dose was injected after a 21-day interval. The sera were collected at intervals of 21, 42 and 63 days after the booster. The humoral response to vaccine was monitored by sandwich enzyme-linked immunosorbent assay (ELISA) and a serum neutralization test (SNT). The guinea pig sera showed high titers both in ELISA and SNT, which could be protective. Further, irrespective of the adjuvant preparation used, the vaccine conferred protection against the challenge virus 105 days post-vaccination in 13 of 15 animals (86%). The results indicated that a combination of recombinant protein ISCOMs and Montanide ISA 206 would be a better choice for achieving early protective titers and longer lasting immunity and that the C-terminal half of the VP1 protein may be tried as a safe vaccine for secondary immunization.Keywords
This publication has 20 references indexed in Scilit:
- Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1Vaccine, 1998
- International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvantsVaccine, 1996
- Antibody response to 146S particle, 12S protein subunit and isolated VP1 polypeptide of foot-and-mouth disease virus type Asia-1Veterinary Microbiology, 1994
- New approaches to vaccination against foot-and-mouth diseaseVaccine, 1992
- Relationship between the anti-FMD virus antibody reaction as measured by different assays, and protection in vivo against challenge infectionVeterinary Microbiology, 1992
- The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolutionNature, 1989
- Protection of Cattle Against Foot-and-Mouth Disease by a Synthetic PeptideScience, 1986
- Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequenceNature, 1982
- Microneutralization tests for serological typing and subtyping of foot-and-mouth disease virus strainsEpidemiology and Infection, 1978
- Enzyme-labelled immunosorbent assay techniques in foot-and-mouth disease virus researchEpidemiology and Infection, 1978